Open AccessAnticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program
Author(s) -
Andrea Tendas,
Luca Cupelli,
Laura Scaramucci,
Massimiliano Palombi,
Malgorzata Monika Trawinska,
Marco Giovannini,
Gregorio Antonio Brunetti,
Claudio Cartoni,
Francesco Bondanini,
Paolo de Fabritiis,
Pasquale Niscola
Publication year - 2011
Publication title -
indian journal of palliative care/indian journal of palliative care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 26
eISSN - 1998-3735
pISSN - 0973-1075
DOI - 10.4103/0973-1075.78450
Subject(s) - medicine , warfarin , anticoagulant , adverse effect , heparin induced thrombocytopenia , low molecular weight heparin , cohort , population , heparin , thrombosis , intensive care medicine , atrial fibrillation , environmental health
Anticoagulants (AC) and anti-platelet (AP) agents are widely administered to patients with hematological malignancies (HM). However, HM patients may be at high risk of bleeding and hemorrhagic complications, because of different form of coagulopathies and several degrees of thrombocytopenia.